Featured Question

I have many patients who have good responses to antidepressants, but have one SIGNIFICANT side effect (weight gain or sexual dysfunction). I am in a dilemma about what to do for them. Should I reduce the dose or switch to another agent (which may not be effective), or should I continue with the treatment knowing that the patient is quite unhappy about the side effect?

See The Answer

Get the latest
science delivered
to your inbox

Answers in CME updates are
available in YOUR specialty.

Sign-up Now!

Featured Activities

12-18-2013

Q&A: Overcoming Challenges in the Treatment of Major Depressive Disorder

Course Director
Ian A. Cook, MD
David Geffen School of Medicine at UCLA
Semel Institute for Neuroscience and Human Behavior
UCLA Brain Research Institute
Los Angeles, California

12-11-2013

Refining the Management of Patients With CLL: Update on Prognostic/Predictive Factors and New Therapies

Course Director
William G. Wierda, MD, PhD
Professor, Department of Leukemia
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, Texas

12-06-2013

Practical Guidance for Overcoming Challenging Patient-Care Issues in MS

Course Director
Daniel Ontaneda, MD, MS
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
Cleveland, Ohio

12-05-2013

Translating an Improved Understanding of Disease Biology Into New Targets and Combinations for the Treatment of Advanced Skin Cancers

Course Director
Antoni Ribas, MD, PhD
Jonsson Comprehensive Cancer Center
University of California Los Angeles
Los Angeles, California

11-27-2013

Overcoming Challenges in Managing Patients With Dermatologic Disorders: A Case-Based Discussion of Atopic Dermatitis, Acne Vulgaris, and Melanoma

Course Director
Steven R. Feldman, MD, PhD
Psoriasis Treatment Center
Wake Forest University School of Medicine
Winston-Salem, North Carolina

11-22-2013

Latest Treatment Advances in MS: Need-to-Know Science and Implications for Practice

Course Director
Daniel Ontaneda, MD, MS
Cleveland Clinic Lerner College of Medicine
Case Western Reserve University
Cleveland, Ohio

11-20-2013

Determining the Optimal Treatment Approach in Advanced Melanoma: Practical Considerations

Course Director
Antoni Ribas, MD, PhD
Jonsson Comprehensive Cancer Center
University of California Los Angeles
Los Angeles, California

11-18-2013

Q&A: New and Emerging Options for the Treatment of Major Depressive Disorder

Course Director
Ian A. Cook, MD
David Geffen School of Medicine at UCLA
Semel Institute for Neuroscience and Human Behavior
UCLA Brain Research Institute
Los Angeles, California

09-17-2013

Cases in Point: Incorporating Novel Therapies for MS into Practice

Course Director
Aaron Boster, MD
The Ohio State University Multiple Sclerosis Center
The Ohio State University Medical Center
Columbus, Ohio

09-17-2013

Q&A: Managing Pediatric and Adolescent Patients with T2DM

Course Director
Chhavi Agarwal, MD
Assistant Professor of Pediatrics
Albert Einstein College of Medicine
Bronx, New York